ADAM three-lens brief
Evidence-based stock research on ADAM. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved -4.29% yesterday. · Trading >3% below the 50-day MA — short-term weakness.
- Moved -4.29% yesterday.
- Trading >3% below the 50-day MA — short-term weakness.
- P/E of 5.7 — trading at a value multiple.
- Analyst mean target $12.13 — 33% above current (6 analysts).
- Debt-to-equity of 769% — balance-sheet-heavy.
ADAM closed at $9.15 (-4.29%) as of 2026-09-11. Market cap: $822.40M. P/E (trailing) 5.7. Price is below the 50-day MA and above the 200-day MA. Positives: p/E of 5.7 — trading at a value multiple.; analyst mean target $12.13 — 33% above current (6 analysts).. Concerns: moved -4.29% yesterday.; trading >3% below the 50-day MA — short-term weakness.. Last quarter: Revenue $50.21M, net income $43.42M.
Why three lenses on ADAM, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ADAMacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ADAM" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ADAM brief"></iframe>